Rituximab

• Description:

  Rituximab anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  148 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  Other Targets

• CAS Number:

  174722-31-7